Home Companion is Patient Experience Intelligence for Hospital-at-Home, post-discharge and specialist pathways — helping patients prepare for, understand and follow through on care between encounters. This framework defines exactly how a pilot is scoped, governed and measured. We measure; we do not promise clinical outcomes.
A pilot exists to answer one question with evidence: does runtime-governed Patient Experience Intelligence improve how patients prepare for, understand and follow through on care — safely, transparently, and under human authority?
Feasibility, acceptability and governance integrity of Home Companion within a defined patient population over 30 days. The pilot produces an evidence pack: engagement data, governance event logs, escalation handling records, and structured patient and clinician feedback.
It is not a clinical trial, a medical device deployment, or a claim of reduced admissions or improved clinical outcomes. Home Companion is non-diagnostic and performs no autonomous diagnosis, treatment, or clinical decision-making, in line with the EU AI Act.
Home Companion is designed for patients navigating care between encounters — where continuity, preparation and follow-through carry the highest burden. A pilot focuses on one population to keep the evidence clean.
Cancer patients and survivors managing complex appointment schedules, side-effect tracking, and information overload between specialist visits.
Long-term conditions (e.g. cardiac, respiratory, diabetes) where daily routine, medication adherence reminders and self-management support reduce avoidable friction.
The fragile window after a hospital stay, where understanding discharge instructions and following through on next steps matters most.
Patients receiving acute or sub-acute care at home, where structured preparation and a clear escalation path support the care team.
Non-clinical, consent-gated patient support that sits alongside — never replaces — the care team.
Every pilot runs on Runtime Governance Infrastructure. Human authority stays at the centre; the AI executes delegated, bounded tasks — and the system enforces those boundaries at runtime.
Aligned with the EU AI Act. Non-diagnostic scope keeps the pilot outside SaMD classification while generating the governance evidence that supports future regulated expansion.
Lightweight by design. Home Companion operates with its own governance layer and requires minimal IT integration to start a pilot.
Capability expansion is earned through governance maturity — never the reverse. Evidence from each stage supports the authorization of the next.
Non-clinical patient experience support. Feasibility, acceptability and governance evidence.
Structured wellbeing monitoring within expanded, still non-diagnostic boundaries — subject to review.
Clinical-grade integration with EHR and escalation pathways — subject to regulatory authorization.
We are selecting a small number of pilot partners for 2026 — regional hospitals, care homes and health insurers. A 30-day pilot is the fastest way to generate evidence that fits your setting.
Apply for a 30-Day Pilot